News : anti-fungal

Moberg Derma AB (publ) has entered into a letter of intent for distribution in the United States. The letter of intent includes Emtrix® – a product for treatment of discolored and deformed nails resulting from fungal infection (onychomycosis) or psoriasis. The intention is to give the distributor an exclusive right to market and sell Emtrix® in the U.S.
"Already the first quarter after launch, Emtrix® is the...

Moberg Derma AB (publ) has entered into distribution agreements with AG Farma S.A. in Spain and HairXpertise Ltd in UK for Emtrix® – for treatment of discolored and deformed nails resulting from fungal infection (onychomycosis) or psoriasis. Under the agreements, the distributors are granted exclusive rights to market and sell Emtrix®.
”The agreements follow on a positive response in the Nordic market. Already...

Moberg Derma AB, Sweden, today announced a commercial agreement with Perrigo Company that covers distribution in Israel for Moberg Derma’s novel topical nail product Emtrix™ – a treatment of discolored and damaged nails caused by nail fungus (onychomycosis) or nail psoriasis. Under the agreement, Moberg Derma assumes supply responsibility, while the distributor will be responsible for registration and promotion in...

The pharmaceutical company Moberg Derma has received a grant of SEK 4,2 million from Vinnova (The Swedish Governmental Agency for Innovation Systems). The grant will be used to develop an innovative patent-protected pharmaceutical product that will further strengthen the company’s position in the area of topical antifungals.
“We are very pleased that we have been awarded this grant which enables a faster...

The pharmaceutical company Moberg Derma recently secured SEK 35 million in a new share issue. Both existing and new shareholders subscribed for shares in the issue. More than SEK 100 million has now been raised for its operations since the company was established in March 2006.
“We are very pleased with the interest shown by investors what has been a difficult market climate in recently. The new share issue has...